PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Immunology, Institute for Cellular and Molecular Medicine, University of Pretoria, Pretoria, South Africa.\', \'South African Medical Research Council (SAMRC) Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.\', \'James and Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.\', \'Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan.\', \'Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.809244
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35046961
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • SARS-CoV-2 Variants, Vaccines, and Host Immunity.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35046961>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35046961>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all